When discounted playing cards may help reduce the load of substantial drug charges while in the short-term, they do not address the systemic issues driving up prescription prices from the U.S. Broader policy improvements could deal with the root causes of mounting drug rates, such as insufficient transparency in pricing plus the function of interme